Current research progress of immunology in clinical reproductive medicine

齐新宇,孔菲,赵捷,王海燕,乔杰
DOI: https://doi.org/10.3877/cma.j.issn.1673-5250.2023.01.001
2023-01-01
Abstract:China has a high incidence of infertility affecting 15%-20% reproductive age people. Human reproductive immune disorder is influenced by many factors, and the role of immunity in clinical reproductive medicine is known by people gradually. Poor oocyte and embryo quality, dysfunction of endometrium, and imbalance of organism environment are all closely related to the imbalance between reproductive health and immune homeostasis. Exploring the important mechanism of immune factors in the pathogenesis of reproductive immune disorders is of great significance for establishing accurate and effective new strategies for the diagnosis and treatment of reproductive immune disorders, as well as improving the reproductive quality of our population in an all-round way. In this paper, we will systematically expound the latest research progress of immunology in clinical reproductive treatment in order to provide new insights for clinical diagnosis and treatment of patients with reproductive immune disorders.
What problem does this paper attempt to address?